Ce tour de table, mené par ChrysCapital et Dragon Funds, souligne l’élan mondial de MoEngage alors que les entreprises dépassent les nuages de marketing traditionnels pour adopter la plateforme d’engagement client de MoEngage, basée sur les connaissances et destinées aux équipes de marketing et de produits.

La demande pour Merlin AI et la suite d’engagement unifié de MoEngage continue d’augmenter en Amérique du Nord, dans la région EMEA, en Australie, en Nouvelle-Zélande et en Asie du Sud-Est, alors que les marques investissent dans des connaissances plus approfondies et des expériences client connectées.

LONDRES, 18 décembre 2025 — MoEngage, la plateforme d’engagement des clients pour les marques de consommation, a annoncé avoir levé 180 millions de dollars supplémentaires dans le cadre de son cycle de série F. Cette somme fait suite aux 100 millions de dollars obtenus en novembre 2025, ce qui porte le montant total de la série F à 280 millions de dollars. Le dernier investissement a été mené par les nouveaux investisseurs ChrysCapital et Dragon Funds, aux côtés de Schroders Capital, avec une participation continue des investisseurs actuels TR Capital et B Capital.

Le capital sera utilisé pour accélérer le développement de la suite Merlin AI, mettre en place des équipes importantes de commercialisation en Amérique du Nord et dans la région EMEA et explorer les acquisitions stratégiques qui élargissent les capacités de la plate-forme. MoEngage poursuite le renforcement de sa présence en Australie, en Nouvelle-Zélande et en Asie du Sud-Est, où les entreprises modernisent leurs systèmes d’engagement client et unifient leurs flux de travail en matière de marketing et de produits.

Parallèlement à ces investissements de croissance, MoEngage a achevé sa deuxième offre publique d’achat destinée aux employés, d’un montant total d’environ 15 millions de dollars, dont bénéficient 259 employés actuels et anciens qui pourront ainsi développer leur patrimoine. Le tour de table comprenait des transactions secondaires sélectionnées pour les investisseurs précoces, à savoir Eight Roads, Helion Venture Partners, Matrix Partners et Ventureast.

« Chez MoEngage, nous pensons que notre réussite est le résultat d’un effort collectif, fondé sur une culture de la responsabilité et de l’innovation. Il est essentiel que nous reconnaissions les personnes qui nous ont contribué à cette réussite », a déclaré Raviteja Dodda, PDG et cofondatrice de MoEngage. « Ce programme de liquidité reflète cet engagement en garantissant que les bâtisseurs de MoEngage, nos employés et les premiers investisseurs ont la possibilité d’être directement associés aux étapes que nous franchissons ensemble. Nous sommes reconnaissants à ChrysCapital, Dragon Funds, Schroders Capital, TR Capital et B Capital pour leur partenariat, qui nous permet de continuer à nous développer à l’échelle mondiale. »

Accélérer la croissance en Europe et au Royaume-Uni

L’Europe et le Royaume-Uni continuent d’être des marchés de croissance clés pour MoEngage, car les entreprises accélèrent leur transformation numérique et adoptent des plateformes d’engagement client basées sur l’IA. En s’appuyant sur sa présence actuelle, l’entreprise prévoit d’accroître ses effectifs dans les deux régions, en renforçant les équipes chargées de la réussite des clients, de l’assistance, des ventes et du marketing, tout en améliorant ses capacités en matière d’IA.

MoEngage collabore avec des entreprises de premier plan dans les domaines de la vente au détail, du commerce électronique, des services financiers et des télécommunications afin d’unifier les données des clients et d’offrir des expériences personnalisées et omnicanales. Ces efforts aident les entreprises dans ces régions à tirer parti de l’IA pour améliorer la rétention et la fidélisation des clients, ainsi que les expériences connectées sur des marchés numériques de plus en plus concurrentiels.

S’appuyant sur son leadership en tant que plateforme d’engagement client pour les spécialistes du marketing, MoEngage renforce sa suite pour les équipes produits grâce à MoEngage Analytics et MoEngage Inform. L’engagement moderne des clients n’étant pas uniquement le fait du marketing, les équipes produits et marketing doivent travailler en utilisant des données communes afin de garantir que les expériences des clients soient connectées et non fragmentées.

MoEngage Inform rationalise les messages transactionnels essentiels, tels que les mots de passe à n’utiliser qu’une seule fois, les mises à jour de compte et les mises à jour de service, via une API unique à travers les canaux de messagerie et les fournisseurs de services, garantissant ainsi une fiabilité distincte des campagnes de marketing. Parallèlement, les capacités améliorées d’analyse des produits de MoEngage Analytics comblent l’écart entre les connaissances et l’action. En unifiant les données comportementales avec l’engagement immédiat, MoEngage permet aux chefs de produit de découvrir les raisons du comportement des utilisateurs et de déclencher instantanément des expériences qui favorisent la fidélisation et la valeur au cours de la durée de vie.

« L’engagement des clients n’a jamais été la responsabilité d’une seule équipe. Les clients traversent de nombreuses expériences qui doivent leur donner l’impression d’être connectés et soutenus », a ajouté M. Dodda. « Lorsque les équipes produits, ingénierie et marketing travaillent à partir des mêmes données et outils, ils peuvent se présenter plus naturellement à leur public. C’est cette expérience que nous voulons aider les entreprises à offrir pour qu’elles puissent développer leurs marques. »

Rishabh Iyer, vice-président de ChrysCapital, a déclaré : « ChrysCapital est ravi de s’associer à MoEngage pour sa prochaine phase de croissance basée sur l’IA. Cet investissement s’inscrit dans notre stratégie consistant à soutenir des plateformes technologiques construites en Inde pour des entreprises internationales, en s’appuyant sur des talents profonds, sur l’efficacité du capital et sur une compréhension détaillée des besoins des entreprises. Nous sommes impressionnés par le modèle d’exploitation rigoureux de MoEngage, son exécution soutenue aux États-Unis et ses vastes capacités en matière de produits. Nous sommes impatients d’aider l’équipe à devenir la première plateforme de technologie de marketing au monde. »

Ridhi Chaudhary, directeur technologique de Dragon Funds, a ajouté : « Nous sommes heureux de nous associer à MoEngage, car la solidité de sa gestion, l’innovation continue de ses produits et sa croissance durable sont impressionantes, Nous pensons que MoEngage propose le meilleur dans sa catégorie et que ses capacités en matière d’IA la placent en bonne position pour devenir le leader en matière de technologies de marketing. » De son côté Aakash Tulsani, directeur général de Dragon Funds, estime : « MoEngage place la barre de l’innovation en exploitant l’IA sur les données de première partie, ce qui la rend essentielle pour les spécialistes du marketing. C’est un privilège d’être à nouveau partenaire de MoEngage, après nos investissements antérieurs. »

« Chez Zeta, nous construisons la pile bancaire moderne pour les principales institutions financières du monde. En tant qu’entreprise axée sur les données, nous nous appuyons sur des informations approfondies sur les clients pour orienter notre stratégie de produits », a déclaré Bhavin Turakhia, cofondateur et PDG de Zeta. « MoEngage Analytics nous a aidé à optimiser les parcours critiques tels que l’accueil, l’activation et la vente croisée, tandis que ses capacités de messagerie nous permettent d’inciter instantanément les clients et combler efficacement le fossé entre la connaissance et l’action. En tant qu’utilisateur du produit, je suis impressionné par l’innovation permanente. En outre, MoEngage Inform est devenu essentiel pour alimenter nos communications critiques, en fournissant des mises à jour de comptes et de transactions avec une fiabilité et une rapidité élevées. »

« MoEngage Inform est devenu un élément essentiel de la façon dont nous gérons notre expérience de commerce électronique chez Loblaw, dans toutes nos activités » a déclaré Charu Pujari, vice-président principal, IA et ingénierie, chez Loblaw Digital. « La plateforme tient les clients au courant de leurs commandes de livraison et de récupération avec la rapidité et la fiabilité qu’ils attendent, ce qui joue un rôel majeur dans l’engagement et la confiance qu’ils ressentent tout au long du processus. »

Avendus Capital a agi en tant que conseiller financier exclusif de l’entreprise et de ses actionnaires.

À propos de MoEngage

Basée à Bangalore et San Francisco, MoEngage est une plateforme d’engagement client axée sur la connaissance, plébiscitée par plus de 1 350 marques mondiales grand public telles que SoundCloud, McAfee, Flipkart, Kayak, Domino’s, Deutsche Telekom ou Travelodge, entre autres. MoEngage aide les spécialistes du marketing et les propriétaires de produits à obtenir des informations sur le comportement des clients et leur donne les moyens d’agir sur la base de ces informations pour entrer en relation avec les clients dans l’ensemble des canaux web, mobiles, sociaux, de courrier électronique et de messagerie. Les professionnels du marketing peuvent utiliser sa suite Merlin AI, composée d’une équipe d’agents d’IA, pour lancer des campagnes plus rapidement et augmenter les conversions de clients grâce à la prise de décision assistée par l’IA. Les marques de consommation dans 75 pays utilisent MoEngage pour offrir des expériences numériques à plus de 2 milliards de consommateurs chaque mois.

MoEngage a été reconnu comme le « choix des clients » dans Gartner Peer Insights™ Voice of the Customer for Multichannel Marketing Hubs, mai 2025 et comme un « acteur très performant » dans The Forrester Wave™ : plateformes de marketing cross-canal pour le 4e trimestre de 2024.

visitez www.moengage.com.

Contact :
Pooja Jain
[email protected]

Logo : https://mma.prnewswire.com/media/2815704/5606360/MoEngage_Logo.jpg

BOSTON, Dec. 17, 2025 — CranioSense, Inc., a neurotechnology company developing the world’s first noninvasive intracranial pressure (ICP) diagnostic and monitoring system, today announced the award of approximately $5.5 million in total non-dilutive funding through the NIH Blueprint MedTech Program and the U.S. Department of Defense’s Joint Warfighter Medical Research Program (JWMRP).

“In over a decade of working to develop Prolonged Casualty Care (PFC) training, doctrine, and equipment, one of the biggest gaps in monitoring critical casualties in austere military and civilian environments has been the inability to effectively track intracranial pressure,” said LTC (Ret.) Doug Powell, MD, former PFC consultant to the U.S. Army Special Operations Command (USASOC) Surgeon’s Directorate. “Noninvasive ICP monitoring has long been considered a ‘Holy Grail’ of PFC, and CranioSense’s work represents a meaningful step toward closing that gap.”

Together, these grants fund initiatives that will directly link CranioSense’s defense-driven work to its mission of improving brain pressure assessment across all levels of civilian care.

“These awards will support device development and pivotal validation, moving CranioSense decisively toward market launch,” said Ryan Myers, PhD, MBA, Chief Executive Officer and Co-Founder of CranioSense. “The Blueprint MedTech and JWMRP programs represent two sides of the same mission: enabling better neurologic care anywhere and everywhere it is needed.”

CranioSense’s technology uses near-infrared optical sensors and proprietary algorithms to deliver real-time, noninvasive diagnosis of elevated brain pressure. Once FDA-approved, the system will make intracranial pressure assessment as routine as blood pressure measurement, bringing much-needed diagnostic support to emergency departments, where rapid decisions matter most. In the future, the platform will measure additional biomarkers tied to acute and chronic brain health, unlocking AI-driven prediction and decision support to guide clinical care.

Leveraging complementary investments made in the Spring of 2025 by multiple angel investors, Illinois Venture Angels, She’s Independent, Heinz Ventures, and Hillside Ventures, the company will continue collaborating with leading clinical and engineering partners to achieve regulatory milestones and prepare for pilot deployment.

About CranioSense
CranioSense, Inc. is a Massachusetts headquartered neurotechnology company developing noninvasive tools to monitor intracranial pressure. Founded in 2023, CranioSense’s mission is to make brain pressure monitoring as safe, simple, and universal as blood pressure measurement.

SOURCE CranioSense

In its 12th year, the program achieved a record $1.5 million raised for the future of agriculture

PRAIRIE DU SAC, Wis., Dec. 17, 2025 — When Culver’s launched its Thank You Farmers Project in 2013, the goal was simple: support the agricultural community and show gratitude to the farmers who feed us. That mission has always included uplifting agricultural education and supporting the caretakers of our land to ensure a viable food supply for years to come. Today, Culver’s is proud to celebrate a record milestone: $8 million in total donations since the program’s inception.

In 2025 alone, thanks to the generosity of guests and local fundraising efforts, more than $1.5 million was raised to benefit the future of agriculture. Culver’s remains committed to strengthening farming for future generations through meaningful partnerships and active community involvement.

“Behind every meal we serve in our restaurants are local hardworking farmers,” said Alison Demmer, Culver’s senior public relations manager. “This year and every year, we’re proud to work alongside our guests to create something truly meaningful, and we’re so thankful to everyone who joined us in furthering our efforts to uplift our next generation of farmers.”

The success of the Thank You Farmers Project relies heavily on the generosity of Culver’s guests, who contribute through donations and participation in special events. Some of the ways that Culver’s and its communities have supported the Thank You Farmers Project this year include:

• Green and Gold: Culver’s donated $1 for each rental and digital purchase of the movie “Green and Gold,” for a total of $100K to three agricultural organizations.
• To Farmers with Love: Hundreds of guests nominated farmers and ranchers for the 2025 “To Farmers with Love Contest,” which rewarded five winners with a $500 cash prize, a VIP Tim McGraw concert experience at the iconic Field of Dreams, Culver’s gift cards and swag.
• Scoops of Thanks Day: Guests donated over $170K in the 11th annual Scoops of Thanks Day fundraiser. The fundraiser offered guests the opportunity to get a single scoop of Fresh Frozen Custard in exchange for a $1 donation to local FFA chapters and other agricultural education organizations.
• Concretes for a Cause: Culver’s raised more than $570K through Concretes for a Cause by donating $1 from each Concrete Mixer sold systemwide over a five-day period to local hunger relief initiatives.
• Culver’s FFA Ambassadors: Guests nominated standout FFA members in their communities to represent Culver’s as FFA Ambassadors and earn prizes for their local chapter. Ten ambassadors earned up to $2,500 to fund learning experiences by participating in agriculture advocacy events in partnership with Culver’s.

Guests can discover more about the impact Culver’s Thank You Farmers Project has had on the future of agriculture since its creation through this infographic.

To learn more about how to get involved or donate to the Thank You Farmers Project, visit https://www.culvers.com/about-culvers/thank-you-farmers-project.

About Culver’s:
For over 40 years, Culver’s guests have been treated to cooked-to-order food made with farm-fresh ingredients and served with a smile. The ever-expanding franchise system now numbers over 1,000 family-owned and operated restaurants in 26 states. The restaurants’ nationally recognized customer service is based on small-town, Midwestern values, genuine friendliness and an unwavering commitment to quality. Signature items include the award-winning ButterBurger, made from fresh, never-frozen beef, and Fresh Frozen Custard, including the famous Flavor of the Day program. For more information, visit www.culvers.com or connect with Culver’s on Facebook, Instagram and TikTok.

CONTACT
Cody Amble
608.256.6357
[email protected]

SOURCE Culver’s

The funding will propel the already profitable company to expand their reach beyond their existing 6000+ clients

SAN FRANCISCO, Dec. 17, 2025 — Arcads.ai, the go-to platform for creating high-performing marketing videos with AI, today announced a round of 16 million dollars in Seed funding led by Eurazeo, with participation from Alpha Intelligence Capital and other international investors including the Sequoia Scout program.

Founded in 2024 by Dylan Fournier and Romain Torres, Arcads.ai is an AI platform that enables marketing teams to produce social-ready videos in minutes: The platform supports multiple high-performing formats — UGC-style AI actors, product demos, fashion try-on videos and unboxing content — available in more than 35 languages. Arcads.ai is now used by thousands of companies worldwide, from app studios and consumer brands to marketing agencies and individual founders.

An entrepreneurial story born from a frontline need

Before Arcads.ai, the two founders had launched a marketing agency, then a mobile app studio that generated several successes. With each launch, the same challenge arose: producing thousands of videos for social media in ultra-competitive environments, without resources comparable to large marketing teams.

Experiencing this structural pain point firsthand led Fournier and Torres to develop Arcads.ai. Within a few months and with a team of seven people, the company has already demonstrated rapid execution and strong traction with over 6,000 clients and 100,000 assets per month. Their mission remains the same: to make fast, scalable, and quality video production accessible, whether it’s for a studio generating millions of dollars or creators without a camera or internal resources.

Accelerating platform development and international presence

More than half of Arcads.ai users today come from the United States. This financing will allow the company to accelerate its growth by: the development of its platform, the broadening of its video generation capabilities, and by strengthening its international presence with an office in San Francisco.

“We created Arcads.ai to break down the barriers that exist when marketing teams need to quickly and affordably create the many videos needed to promote a product. We, ourselves, experienced this difficulty for years. With Arcads.ai, we are making this process accessible, simple, and iterative: test, adjust, repeat,” said Dylan Fournier, co-founder & Co-CEO of Arcads.ai. He continued, “The results already speak for themselves, we’re already profitable and this funding will give us the means to accelerate our development and support the growth of our user base, particularly in the United States.”

“In almost all the markets we follow, the battle is now played out in distribution, making one’s brand and product known. Arcads.ai gives marketing teams a structural advantage in this competition for attention, and the international traction we are observing confirms it. We are happy to accompany Arcads.ai in this new stage,” added Thomas Turelier, Managing Director, Venture Digital, Eurazeo.

Read more about funding here.

About Arcads.ai

Arcads.ai is a French company specializing in the automated generation of marketing videos from AI actors. The platform helps marketing teams, app studios, brands, and entrepreneurs quickly produce videos adapted for social networks, acquisition campaigns, and localization needs. Founded in 2024, Arcads.ai now supports over 6,000 clients worldwide. For more information, visit Arcads.ai.

About Eurazeo

Eurazeo is a leading European investment group managing 37.4 billion euros in diversified assets, including 28.0 billion on behalf of institutional and private clients through its private equity, private debt, real estate, and infrastructure strategies. The Group supports more than 600 Mid-Market companies, providing their development with the commitment of its 400 employees, its sectoral expertise, and its privileged access to global markets via its offices in Paris, New York, London, Frankfurt, Berlin, Milan, Stockholm, Madrid, Luxembourg, Shanghai, Seoul, Singapore, Tokyo, and São Paulo.

SOURCE Arcads.AI

RESEARCH TRIANGLE PARK, N.C. and NEWPORT BEACH, Calif., Dec. 17, 2025 — ClinTrial Research (CTR) announced today that it has closed a growth equity round led by Tarsadia Investments, a multi-billion-dollar firm that makes high-conviction investments in category-defining companies globally. The investment reflects Tarsadia’s conviction that CTR is positioned to become the leader in the clinical site network sector.

“We fully believe in CTR’s mission to build the industry’s most trusted clinical site network—one that brings together exceptional people, advanced technology, and strong therapeutic leadership to elevate patient care and drive lasting innovation,” said Rishi Reddy, Managing Director and Head of Venture and Growth Equity at Tarsadia.

CTR CEO Sam Searcy emphasized that the partnership is far more than a capital infusion. “This investment from Tarsadia is a powerful vote of confidence from a respected industry leader with significant financial and strategic resources. It reinforces CTR’s position as a category-defining business,” Searcy said. “From our first meeting with the Tarsadia team last summer, the cultural alignment was immediate. It felt like speaking with close colleagues—effortless, natural, and an extension of our own team. Their intellectual depth and strategic insight are exceptional.”

The need for high-performing clinical site networks continues to grow. More than 90% of physicians who participate in a clinical trial never conduct a second one. When combined with staffing shortages, increasingly complex study protocols, and rising drug development costs, the importance of efficient, well-structured site networks becomes even more critical. “A site network that can solve across these four industry challenge areas will become a lasting and essential part of the pharmaceutical development ecosystem,” Searcy added. “We are confident we are building exactly that—approaching each challenge with precision, innovation, and the right long-term strategy.”

Reddy noted that CTR stood out clearly among companies evaluated. “CTR is led by a seasoned team who brings a modern, innovative approach to site networks and site management,” he said. “Critically, CTR and Tarsadia are aligned in their focus on bespoke AI-enabled technology platforms and the transformative impact they can have on the site network sector. Tarsadia invests with conviction in companies we believe are shaping the future and positioned for significant growth. After more than two years of analyzing the site network landscape, CTR was the team that checked every box for us: innovative, collaborative, AI-forward, and agile in a rapidly evolving market.”

SOURCE Clintrial Research

SAN FRANCISCO, Dec. 17, 2025 — Tokenfolio, an active growth stage and pre-IPO tech investor, has been ramping up their institutional arm to better serve increasing demand from institutional investors to access top AI investments.

Tokenfolio are early investors in most of the top 10-15 high-profile AI startups in Silicon Valley and are currently focusing on investing early in what will become the top private market names of tomorrow. Tokenfolio typically invests in Series B through pre-IPO.

Their portfolio includes some of the top tech companies in AI infrastructure, AI robotics, and deep tech AI – for many of these, they joined highly oversubscribed funding rounds co-investing with world’s top funds like Sequoia, Lightspeed, Amazon founder Jeff Bezos (Bezos Expeditions), sovereign wealth funds and more.

Currently, reputed billionaire families in APAC, senior tech leaders, entrepreneurs with successful exits, and regulated funds invest with Tokenfolio. Beyond investments, Tokenfolio works closely with their portfolio companies to help them expand, especially across APAC given their active network and experience.

“Given increasing demand from our institutional LPs, it’s our key focus to ensure we can continue to follow industry leading processes as we scale. For this, we’re actively ramping up our efforts including partnering with market leaders to provide our LPs with best in class structures and services,” said Abhishek Malik, co-founder and CEO.

Most recently, Tokenfolio partnered with Carta in order to provide their investors with institutional grade fund administration services. Carta is one of the largest fund administrators in the world with over $180B assets under administration and 2,000 employees across 14 offices worldwide, and is uniquely positioned to service Tokenfolio’s global client base. Carta will serve as an independent third party fund administrator for Tokenfolio vehicles. Carta is backed by some of the largest VC funds, private equity funds and investment managers in the world, including a16z, Silver Lake and ICONIQ Capital.

Carta’s Dinesh Manivannen, Account Executive from their Funds team, said, “We’re excited to partner with Tokenfolio. Their rapid growth is impressive, we have the right expertise and tools to support them and their LPs as they keep scaling further.”

Abhishek added, “Appointing Carta confirms our commitment to delivering the most trusted, safe and robust way for investors to access some of the world’s best AI and deep tech investment opportunities across growth stage and pre-IPO investing.”

Tokenfolio’s move to Carta is a step towards ensuring its investors receive the same rigor, transparency and auditability previously reserved for large public market investors.

About Tokenfolio

Tokenfolio is a growth stage AI and deep tech investor that provides access to top Silicon Valley tech companies. An early investor in most of the top 10-15 high-profile AI startups, with a key focus on disciplined underwriting, Tokenfolio aims to invest today in companies that become the top private market names of tomorrow.

Logo: https://mma.prnewswire.com/media/2847479/TokenFolio_Logo.jpg

SOURCE Tokenfolio

MUSCAT, Oman, Dec. 17, 2025 — Future Fund Oman announced record activity in 2025, approving 141 projects this year and lifting total commitments to $1.2 billion as the fund accelerates Oman’s economic diversification agenda.  Established by Oman Investment Authority with a capital commitment of $5.2 billion to be deployed over five years, the fund is now one of the region’s fastest-expanding national investment vehicles, with all capital directed toward projects inside Oman and aligned with the priorities of Oman Vision 2040.

Investment activity has drawn growing private-sector participation from the United States, United Arab Emirates, Saudi Arabia, Egypt, China, and India. To date, Future Fund Oman has mobilized approximately $2.1 billion in additional private and foreign capital, including eight large-scale projects developed alongside global investors, banks, funds, and family offices. The fund said the rising leverage ratio reflects strengthening international confidence in Oman’s industrial, manufacturing, and clean energy ambitions.

Job creation remains a key performance indicator. Projects approved since launch have generated more than 1,400 jobs, with thousands more in progress. Investments span five national priority clusters , energy transition, advanced materials, healthcare, logistics, and information and communications technology, reinforcing the fund’s role in shaping the country’s next phase of economic growth.

Flagship developments include a $1.6 billion solar-grade polysilicon manufacturing facility by United Solar, scheduled for completion in 2026. The project has already supported over 1,000 jobs and delivered more than $317 million in in-country value, while also attracting interest from international development finance institutions. Another major project is JA Solar’s six-gigawatt solar cell manufacturing complex in the SOHAR Port and Freezone, a $442 million investment nearing key construction milestones. Once operational, the facility is expected to employ more than 500 people and expand Oman’s foothold in regional clean energy supply chains.

Momentum also continues under the fund’s SME and venture capital mandate. Since inception, 132 SME and VC projects have been approved, with $56.7 million committed and $37.4 million deployed through eight specialized vehicles covering pre-seed, seed, growth equity, and SME debt. Application volumes remain strong across both mandates, driven by sustained domestic and international interest in projects linked to industrial modernization, technology development, and clean energy.

Since launch, the fund has assessed 828 proposals and approved 141 projects valued at around $3.4 billion, spanning nine major strategic investments and 132 SME and venture capital initiatives. Its dual mandate guides capital toward both large national projects and smaller high-growth businesses, with a targeted 12 percent return and a 40 percent equity ceiling per investment.

Media contact:

OIA Press Office
Mobile: +968 92278104
Email: [email protected]

Photo – https://mma.prnewswire.com/media/2847853/OMAN_INVESTMENT_AUTHORITY.jpg

OTTAWA, ON, Dec. 17, 2025 – New Canadian technology company Woodway Assurance is proud to announce that it has closed an oversubscribed seed funding round for its flagship product, EviData™, raising $1 million. This shows strong investor conviction that independent, standards-aligned and automated data assurance is becoming a necessary layer for data-driven organizations, and confidence that Woodway’s management team, with its deep experience in researching, developing and commercializing privacy enhancing technologies, is well positioned to deliver it. The round was led by Aventure Capital, with participation from other angel investors.

“EviData addresses a growing pain point for organizations trying to clear roadblocks to responsible data use. I was very impressed with the vision for this transformative product, its significant potential and the plans for bringing it to market,” said Aventure Capital co-founder Frederic Boulanger. “We expect the solution to become an essential layer in the modern data stack.”

Organizations across health and life sciences, financial services and other sectors depend on data for research, analytics and AI projects, but they are under growing pressure to prove that their de-identification practices can stand up to scrutiny. When organizations, partners or clients don’t have the technical expertise to verify claims that datasets are properly de-identified, decisions can stall or default to a “no.” EviData is the first-of-its-kind software solution designed to turn that into a managed and defensible “yes” so data can be accessed, used and shared responsibly.

Running inside the client’s environment and requiring minimal expertise, EviData uses AI-driven automation to assess an uploaded de-identified or synthetic dataset for privacy and utility. Within minutes it generates a clear, auditable third-party report with documented and reliable evidence of whether a dataset can be treated as non-personal information, mapped to guidance from Canadian regulators and the ISO standards.

“It’s no longer enough for data teams to say they protect privacy. They now have to prove they’re meeting contemporary standards,” said Dr. Khaled El Emam, founder and CEO of Woodway Assurance, Canada Research Chair in Medical AI at the University of Ottawa. “This funding will help us reach more organizations that need a practical way to comply with privacy rules and show with independent evidence that their data can be trusted, so they can get faster approvals without losing data utility. EviData makes that assurance fast, repeatable and reliable so teams can keep innovating with their data and AI projects.”

Woodway Assurance launched in early fall 2025, EviData is already in market and being deployed with early customers to support research, analytics and product development across multiple data-intensive sectors, and the company is already generating revenue. The new funding will help accelerate the company’s growth by building out its capacity in sales, marketing and customer success, and by continuing to enhance the technological capabilities of EviData that are helping organizations scale de-identification assurance across projects.

SOURCE Woodway Assurance

Built on Google Cloud infrastructure, Drive Health is expanding Avery’s clinical workflow and operational capabilities, building toward broader health system and health plan deployment and a planned Series A in 2026.

MIAMI, Dec. 17, 2025 — Vitalis Ventures, an investment platform focused on AI enabled healthcare technology companies advancing next-generation care delivery, announces a strategic $15 million investment in Drive Health, the healthcare technology company behind Avery, a Google-powered agentic AI platform designed to transform how patients navigate care and alleviate the workload placed on clinicians. The total investment includes an additional tranche scheduled to close in Q1 2026. Vitalis Ventures partnered with Inside Capital Partners on the transaction.

This latest investment from Vitalis Ventures brings the total capital committed to Drive Health to $26+ million. The funding marks a significant step in Drive Health’s expansion as the company looks toward a Series A in 2026 and continues to advance its collaboration with Google to deliver scalable, clinically aligned AI support across health systems, managed care organizations and population health plans. Upon completion of the second tranche, Vitalis Ventures will join Drive Health’s Board of Directors, with a focus on strengthening and developing partnerships throughout the healthcare ecosystem.

“This partnership marks a major inflection point for Drive Health,” said Kevin Longoria, CEO of Drive Health. “Vitalis brings real operational depth, health-system experience, and the long-term vision needed to scale Avery responsibly. With their support, and through our continued work with Google, we are accelerating our ability to deliver safe, accessible, and compassionate AI support to healthcare facilities and patients nationwide.”

“Drive Health developed the lowest latency, most comprehensive and clinically aligned workflow automation platform in the market, with the potential to meaningfully reshape how care teams manage communication and follow-up,” said Elliot LaBreche, Founder and CEO of Vitalis. “We believe Avery’s approach to continuity-of-care represents the future of patient support, and we are proud to partner with the Drive Health team as they scale the platform nationwide.”

Avery is Drive Health’s flagship AI-enabled clinical workflow engine, built to support nurses and care teams in managing high-volume communication, education, and coordination tasks with patients and families. Avery automates well-defined units of work such as discharge orchestration, secure-message triage, and follow-up outreach, operating under hospital-defined rules and risk caps.

Integrated directly into clinical workflows, Avery can draft and deliver clinician-approved education, collect symptom and adherence information, and route issues for review based on safe escalation criteria across episodes like pregnancy, chronic disease management, and post-discharge recovery. By handling routine questions and administrative tasks under strict human oversight, Avery helps healthcare providers operate more efficiently while allowing doctors and nurses to focus their expertise on high-touch, in-person care.

Avery is designed to support, not replace, the judgment of licensed clinicians. It does not independently diagnose, treat, or prescribe, and every workflow runs with human-in-the-loop controls, audit logging, and safety governance.

Backed by Google and built on Google Cloud’s healthcare-grade infrastructure, Avery can communicate in more than 15 languages and operate with enterprise-level security, speed, and scale. Beginning in 2024, Drive Health and Google partnered to deepen Avery’s contextual reasoning, cybersecurity, enterprise scalability, and health-system integration, a collaboration that positions Avery as one of the most advanced AI solutions entering the market today. To ensure Avery evolves in step with clinical needs, safety and regulatory standards, the platform is developed in close collaboration with front-line nurses and clinicians through Drive Health’s Clinical Advisory Council. Drive Health also maintains a Clinical Safety Committee which brings interprofessional voices to AI governance and patient-safety.

With this latest capital commitment, Drive Health gains strategic funding and the opportunity to leverage Vitalis’ deep experience partnering with healthcare systems. This expertise in patient flow, operational bottlenecks, and workforce challenges will help Drive Health accelerate deployment and adoption across payers and providers.

Drive Health and Google are also supporting the State of Illinois’ Healthy Baby initiative, a multi-year program aimed at improving maternal and infant outcomes in underserved communities. The initiative will support more than 56,000 participating families with Google Pixel devices, Fitbit technology, and AT&T connectivity, while Avery delivers clinician-approved education, appointment reminders, and structured symptom check-ins from pregnancy through postpartum under the supervision of clinicians.

As Drive Health prepares for its upcoming Series A, the company plans to expand Avery into additional care pathways, explore innovative regulatory approaches, deepen health system integrations, and grow its team of clinical experts guiding the evolution of the platform, with the long-term goal of making continuous access to care available to every patient, everywhere.

About Drive Health

Drive Health turns AI workflows into audited clinical systems where every action is measured, governed, and proven. Avery, Drive Health’s clinical workflow engine, automates well-defined nursing and care-team tasks like discharge orchestration, secure-message triage, and rounding follow-up. Avery is designed to support, not replace, the judgment of licensed clinicians. It does not independently diagnose, treat, or prescribe. Each workflow operates under hospital-defined risk caps, human-in-the-loop controls, and continuous monitoring for safety and performance review. For more information, visit DriveHealth.ai.

About Vitalis

Vitalis Ventures invests in AI-enabled healthcare technology companies to improve access, quality, and efficiency across the U.S. health system. Their thesis is informed by years of operating a portfolio of outpatient medical, surgery center and behavioral health facilities, which gives the team a unique understanding of how patients move through the health system, where bottlenecks occur, and how technology can increase efficiencies & reduce cost. Vitalis Ventures backs companies that solve the industry’s most urgent structural challenges—most notably the nationwide labor shortage, diagnostic delays, gaps in care coordination, and rising costs. To learn more about Vitalis, visit https://vitalisventures.ai/.

About Inside Capital Partners

Inside Capital Partners (“INSIDE”) is a Venture Growth Fund focused on investing in and scaling innovative AI and deep health tech solutions. By leveraging deep relationships with health systems, industry leaders, government entities, and domestic as well as international partners, INSIDE unlocks significant value for companies, health systems, and the overall U.S. healthcare market. To learn more about INSIDE, visit: https://insidecapitalpartners.com/

Media Contact:
Monocle PR
Gaby Harris
[email protected]

SOURCE Vitalis